RELIATECT(TM) POST-OP DRESSING WITH CHG
Report
- Report Number
- 3003764829-2018-00004
- Event Type
- Injury
- Date Received
- April 19, 2018
- Date of Event
- November 14, 2017
- Report Date
- April 19, 2018
- Manufacturer
- AVERY DENNISON CORPORATION
- Product Code
- FRO
- PMA / PMN Number
- K163529
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- OTHER
Narratives
A CLINICIAN REPORTED THAT THE DEVICE ADHERED TO THE SKIN AND REMOVED THE DERMABOND. IT WAS ALSO NOTED THAT THE DRESSING STUCK TO THE SUTURE TAILS AT THE END OF THE INCISION PULLING UP THE SCABS AND CAUSING THE INCISION TO BLEED. NO MEDICAL INTERVENTION WAS REPORTED. THE PART NUMBER AND LOT NUMBER WERE NOT PROVIDED FOR THE COMPLAINT. THEREFORE, BOTH SIZES OF THE POST-OP DRESSINGS WERE EVALUATED AS PART OF THE COMPLAINT INVESTIGATION. SINCE THIS CONSERVATIVE APPROACH WAS EMPLOYED, ALL PRODUCTION LOTS SHIPPED WITHIN THE COMPLAINT TIME FRAME WERE TREATED AS SUSPECT AND EVALUATED. BASED ON THE NATURE OF THE INCIDENT, RETAIN SAMPLES WERE TESTED FOR ADHESION AND RELATED PERFORMANCE CHARACTERISTICS. ALL THE RESULTS WERE FOUND TO BE WITHIN SPECIFICATIONS. IN ADDITION, AVERY DENNISON CONDUCTED A DEVICE HISTORY RECORD REVIEW FOR ALL SUSPECTED LOTS. THE REVIEW CONFIRMED THAT THE PERFORMANCE CHARACTERISTICS WERE WITHIN SPECIFICATION AT THE TIME OF PRODUCT RELEASE. IT IS ALSO IMPORTANT TO NOTE THAT THE IFU FOR THE CONCOMITANT SKIN CLOSURE DEVICE STATES THAT A DRY WOUND DRESSING, SUCH A GAUZE, MAY BE APPLIED AFTER THE ADHESIVE HAS BEEN COMPLETELY POLYMERIZED. THE RELIATECT(TM) IS NOT CONSIDERED A DRY WOUND DRESSING.
A CLINICIAN REPORTED THAT THE DRESSING REMOVED THE DERMABOND ON THE INCISION SITE AND PULLED AT THE SCABS CAUSING THE INCISION TO BLEED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 287497 | RELIATECT(TM) POST-OP DRESSING WITH CHG | DRESSING, WOUND, DRUG | FRO | AVERY DENNISON CORPORATION | MED 9903MS OR MED 9904MS | NOT PROVIDED |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 40 YR | Other |